DrugPatentWatch Database Preview
Drugs in Development Information for PF-04457845
» See Plans and Pricing
What is the drug development status for PF-04457845?
PF-04457845 is an investigational drug.
There have been 9 clinical trials for PF-04457845.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2012.
The most common disease conditions in clinical trials are Stress Disorders, Traumatic, Chronic Pain, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Pfizer, Yale University, and National Institute on Drug Abuse (NIDA).
Summary for PF-04457845
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 5 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2012-06-01) |
| Vendors | 44 |
Recent Clinical Trials for PF-04457845
| Title | Sponsor | Phase |
|---|---|---|
| A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder | Pfizer | Phase 2 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome | Tourette Association of America | Phase 2 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome | Yale University | Phase 2 |
Clinical Trial Summary for PF-04457845
Top disease conditions for PF-04457845
Top clinical trial sponsors for PF-04457845
US Patents for PF-04457845
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
